atogepant
Sign in to saveAlso known as (3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide, AGN-241689, MK-8031, Qulipta
Atogepant, sold under the brand name Qulipta among others, is a medication used to prevent migraines. It is a gepant, a calcitonin gene-related peptide receptor antagonist administered orally.
Key facts
- Drug.image
- Atogepant.svg
- Drug.image_class
- skin-invert-image
- Drug.tradename
- Qulipta, Aquipta
- Drug.MedlinePlus
- a621052
- Drug.DailyMedID
- Atogepant
- Drug.pregnancy_AU
- B3
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- N02
- Drug.ATC_suffix
- CD07
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.CAS_number
- 1374248-81-3
- Drug.PubChem
- 72163100
- Drug.DrugBank
- DB16098
- Drug.ChemSpiderID
- 59718640
- Drug.UNII
- 7CRV8RR151
via Wikipedia infobox
~3 min read
Encyclopedic overview
4 sectionsContents
- Medical uses
- History
- Research
- References
Atogepant, sold under the brand name Qulipta among others, is a medication used to prevent migraines. It is a gepant, a calcitonin gene-related peptide receptor antagonist administered orally.
The most common side effects include nausea, constipation, tiredness, somnolence (sleepiness), decreased appetite, and decreased weight.
Excerpted from Wikipedia’s “atogepant” article, available under the CC BY-SA 4.0 licence.